These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12544508)

  • 1. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.
    Liljedahl U; Karlsson J; Melhus H; Kurland L; Lindersson M; Kahan T; Nyström F; Lind L; Syvänen AC
    Pharmacogenetics; 2003 Jan; 13(1):7-17. PubMed ID: 12544508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.
    Liljedahl U; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L; Kurland L
    J Hypertens; 2004 Dec; 22(12):2321-8. PubMed ID: 15614026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
    Kurland L; Liljedahl U; Karlsson J; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L
    Am J Hypertens; 2004 Jan; 17(1):8-13. PubMed ID: 14700505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
    Liljedahl U; Lind L; Kurland L; Berglund L; Kahan T; Syvänen AC
    BMC Cardiovasc Disord; 2004 Sep; 4(1):16. PubMed ID: 15453913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
    Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman KP; Nyström F; Hägg A; Lind L;
    J Hypertens; 2001 Oct; 19(10):1783-7. PubMed ID: 11593098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
    Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
    Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
    Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
    J Hypertens; 2002 Apr; 20(4):657-63. PubMed ID: 11910301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
    Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
    Am J Hypertens; 2002 May; 15(5):389-93. PubMed ID: 12022239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
    Hallberg P; Karlsson J; Kurland L; Lind L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
    J Hypertens; 2002 Oct; 20(10):2089-93. PubMed ID: 12359989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies.
    Shi MM
    Clin Chem; 2001 Feb; 47(2):164-72. PubMed ID: 11159763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of antihypertensive drug responses.
    Schwartz GL; Turner ST
    Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-chromosomal SNPs in Finno-Ugric-speaking populations analyzed by minisequencing on microarrays.
    Raitio M; Lindroos K; Laukkanen M; Pastinen T; Sistonen P; Sajantila A; Syvänen AC
    Genome Res; 2001 Mar; 11(3):471-82. PubMed ID: 11230171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex SNP genotyping in pooled DNA samples by a four-colour microarray system.
    Lindroos K; Sigurdsson S; Johansson K; Rönnblom L; Syvänen AC
    Nucleic Acids Res; 2002 Jul; 30(14):e70. PubMed ID: 12136118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
    Hallberg P; Lind L; Michaëlsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
    J Hypertens; 2003 Mar; 21(3):621-4. PubMed ID: 12640257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
    J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minisequencing on oligonucleotide microarrays: comparison of immobilisation chemistries.
    Lindroos K; Liljedahl U; Raitio M; Syvänen AC
    Nucleic Acids Res; 2001 Jul; 29(13):E69-9. PubMed ID: 11433045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping single nucleotide polymorphisms by multiplex minisequencing using tag-arrays.
    Milani L; Syvänen AC
    Methods Mol Biol; 2009; 529():215-29. PubMed ID: 19381977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Hallberg P; Lind L; Billberger K; Michaelsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
    Clin Cardiol; 2004 Mar; 27(3):169-73. PubMed ID: 15049387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.